© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
SI-BONE, Inc. (SIBN) stock surged +1.74%, trading at $18.70 on NASDAQ, up from the previous close of $18.38. The stock opened at $18.54, fluctuating between $18.30 and $18.80 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 18.54 | 18.80 | 18.30 | 18.70 | 550.95K |
| Sep 11, 2026 | 18.65 | 19.16 | 18.21 | 18.38 | 590.9K |
| Sep 10, 2026 | 18.45 | 18.69 | 17.99 | 18.30 | 686.07K |
| Sep 09, 2026 | 18.82 | 18.88 | 18.33 | 18.41 | 437.52K |
| Sep 08, 2026 | 18.25 | 18.85 | 18.16 | 18.62 | 541.59K |
| Sep 04, 2026 | 18.50 | 18.75 | 18.20 | 18.50 | 389.53K |
| Sep 03, 2026 | 19.45 | 19.65 | 18.55 | 18.64 | 632.45K |
| Sep 02, 2026 | 18.92 | 19.72 | 18.92 | 19.16 | 786.83K |
| Sep 01, 2026 | 19.12 | 19.46 | 18.62 | 18.92 | 560.38K |
| Aug 31, 2026 | 19.01 | 19.17 | 18.81 | 19.02 | 301.89K |
| Aug 28, 2026 | 19.38 | 19.61 | 19.14 | 19.21 | 361.04K |
| Aug 27, 2026 | 19.40 | 19.68 | 19.17 | 19.20 | 629.26K |
| Aug 26, 2026 | 19.50 | 19.95 | 19.24 | 19.43 | 600.06K |
| Aug 25, 2026 | 19.48 | 19.70 | 19.30 | 19.54 | 557.78K |
| Aug 24, 2026 | 20.00 | 20.30 | 19.42 | 19.47 | 699.82K |
| Aug 21, 2026 | 19.47 | 20.05 | 19.27 | 19.96 | 1.29M |
| Aug 20, 2026 | 19.66 | 19.75 | 19.11 | 19.48 | 518.04K |
| Aug 19, 2026 | 19.14 | 19.92 | 19.14 | 19.91 | 436.39K |
| Aug 18, 2026 | 18.86 | 19.42 | 18.86 | 19.14 | 499.05K |
| Aug 17, 2026 | 18.82 | 18.86 | 18.49 | 18.69 | 481.55K |
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
| Employees | 376 |
| Beta | 0.7 |
| Sales or Revenue | $138.89M |
| 5Y Sales Change% | 0.038% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |